Most recently, the oncolytic human herpes simplex virus 1 (HSV-1) carrying the granulocyte macrophage colony-stimulating factor (GM-CSF), known as T-VEC, was approved for melanoma treatment [10]. Here, CSF2 is linked to melanoma.